Parents' COVID‐19 vaccine intentions for children under 5 years: Brief reflections from a qualitative study

Author:

Attwell Katie12ORCID,McKenzie Lara1ORCID,Tomkinson Sian1ORCID,Carlson Samantha J12ORCID,Blyth Christopher C2ORCID

Affiliation:

1. School of Social Sciences The University of Western Australia Perth Western Australia Australia

2. Wesfarmers Centre of Vaccines and Infectious Diseases Telethon Kids Institute Perth Western Australia Australia

Abstract

AimAustralian authorities made COVID‐19 vaccines available for children aged under 5 years old with serious comorbidities in August 2022. There is presently no universal programme for young children, but crucial to any rollout's success is whether parents are motivated and able to vaccinate. By examining parents' vaccine intentions, this study aims to inform current and future COVID‐19 vaccine roll‐outs for children aged under 5 years.MethodsAs part of the mixed methods project ‘Coronavax: Preparing Community and Government’ we interviewed 18 Western Australian parents of young children about their intentions in late 2021.ResultsTwo thirds intended to vaccinate if and when they could, with one third intending to delay for reasons including risk and safety perceptions, fears about side effects and influence from their social networks. However, even those choosing to delay were waiting rather than refusing.ConclusionsTo improve uptake, targeted messaging should emphasise that COVID‐19 can be a serious disease in young children, with such messaging drawing on the reputability and esteem of scientific and technical authorities. Such messaging should be oriented towards parents of children with serious comorbidities at the present time. It will be important to emphasise that government vaccine recommendations are based on supporting families to protect their children and keep them healthy.

Publisher

Wiley

Subject

Pediatrics, Perinatology and Child Health

Reference19 articles.

1. Australian Government: Department of Health and Aged Care.ATAGI Recommendations on COVID‐19 Vaccine Use in Children Aged 6 Months to <5 Years [Internet]; 3 August 2022 [cited 2022 Oct 25]. Available from:https://www.health.gov.au/news/atagi-recommendations-on-covid-19-vaccine-use-in-children-aged-6-months-to

2. Covid-19: CDC and FDA approve Pfizer and Moderna vaccines for under 5s

3. Health Canada.Health Canada Authorizes Use of Moderna COVID‐19 Vaccine in Children 6 Months to 5 Years of Age [Internet]; 14 July 2022 [cited 2022 Oct 25]. Available from:https://www.canada.ca/en/health‐canada/news/2022/07/health‐canada‐authorizes‐use‐of‐moderna‐covid‐19‐vaccine‐in‐children‐6‐months‐to‐5‐years‐of‐age.html

4. Caregivers’ intentions regarding pandemic (H1N1) 2009 influenza vaccination for their children

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3